5,6-dihydro-5-azacytidine has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krečmerová, M; Otmar, M | 1 |
| Brabant, W; Daifuku, R; Gall, A; Harris, KS; Styrchak, S | 1 |
1 review(s) available for 5,6-dihydro-5-azacytidine and HIV Coinfection
| Article | Year |
|---|---|
5-azacytosine compounds in medicinal chemistry: current stage and future perspectives.
Topics: Animals; Anti-HIV Agents; Antineoplastic Agents; Azacitidine; Cytosine; DNA Methylation; Drug Discovery; HIV; HIV Infections; Humans; Neoplasms | 2012 |
1 other study(ies) available for 5,6-dihydro-5-azacytidine and HIV Coinfection
| Article | Year |
|---|---|
KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis.
Topics: Animals; Anti-HIV Agents; Azacitidine; Cell Line; Cricetinae; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Mutation; Nucleosides; Reverse Transcriptase Inhibitors; Zidovudine | 2005 |